Prihlásiť sa Zaregistrujte sa zadarmo

Výnos na zamestnanca spoločnosti Inhibrx

Aká je hodnota metriky Výnos na zamestnanca spoločnosti Inhibrx?

Hodnota metriky Výnos na zamestnanca spoločnosti Inhibrx, Inc. je $17.481k

Aká je definícia metriky Výnos na zamestnanca?

Výnosy na zamestnanca (Revenue per employee - RPE) je výnos spoločnosti vydelený počtom zamestancov.

Výnos na zamestnanca spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Inhibrx

Čomu sa venuje spoločnosť Inhibrx?

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

Firmy s metrikou výnos na zamestnanca podobnou spoločnosti Inhibrx